The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B.

Shapiro, Amy D; Di Paola, Jorge; Cohen, Alice; Pasi, K John; Heisel, Margaret A; Blanchette, Victor S; Abshire, Thomas C; Hoots, W Keith; Lusher, Jeanne M; Negrier, Claude; Rothschild, Chantal; Roth, David A

Shapiro, Amy D; Di Paola, Jorge; Cohen, Alice; Pasi, K John; Heisel, Margaret A; Blanchette, Victor S; Abshire, Thomas C; Hoots, W Keith; Lusher, Jeanne M; Negrier, Claude; Rothschild, Chantal; Roth, David A.

Affiliation

Shapiro AD; Indiana Hemophilia and Thrombosis Center, Indianapolis 46260, USA. ashapiro@ihtc.org

Blood ; 105(2): 518-25, 2005 Jan 15.

Article in En | MEDLINE | ID: mdl-15383463

Subject(s)

Factor IX/administration & dosage; Hemophilia B/drug therapy; Hemorrhage/prevention & control; Adolescent; Blood Loss, Surgical/prevention & control; Child; Child, Preschool; Factor IX/adverse effects; Female; HIV Infections/diagnosis; Hepatitis A/diagnosis; Humans; Infant; Infant, Newborn; Male; Recombinant Proteins/administration & dosage; Recombinant Proteins/adverse effects; Severity of Illness Index; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Factor IX / Hemophilia B / Hemorrhage Type of study: Clinical_trials / Diagnostic_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Language: En Journal: Blood Year: 2005 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links